Latest news for Altiplano Metals (OTC:ALTPF) Stock

Altiplano Metals Inc is a Canadian mineral development company focused on acquiring projects with the potential for advancement from discovery through to production. The company has a diversified portfolio of assets that include an operating copper/gold/iron mine, development of near-term producing gold/copper projects, and exploration land packages with district-scale potential. Some of the projects include the Santa Beatriz Project, Maria Luisa Property, Farellon Property, and Pastillas Gold Project.

News

Movers & Shakers

Intraday Update

Markets

Movers

Trading Ideas

General

AAMAF

ADOM

AFPW

AGLNF

AIHS

AITX

ALTPF

AMCR

ATRX

AXION VENTURES INC by Axion Ventures Inc.

AXNVF

BKTPF

BRGO

CARB

CELC

CHMI

CHMJF

CLSH

CRRVF

CWLDF

DGLY

ENDO

ERAO

FNJN

FPLPY

GLYE

HLUYY

ITAYY

JAPAF

KGET

KLXE

KMPH

KZMYY

LGF-A

LGF-B

LLIT

MFCSF

MKRS

MNTR

MSBHY

MSGN

NGPHF

NKTR

PGHEF

PHCF

PLCE

PMCB

PNRL

PURE

QADB

RASFO

RCRT

RNSDF

RSNHF

RSSFF

RUTH

SCSC

SHEN

SMHI

TCNAF

THCBF

TRIB

UCBJY

VIRA

WINS

XBOR

YBAO

EBBGF

ASUUY

BBAJF

FRRPF

DSUS

CANF

CLYXF

BKIT

Stocks That Hit 52-Week Lows On Wednesday

AAWW

ABBV

ABEO

ACER

ACGBF

ACGBY

ACOR

ACRGF

ACRS

ADAP

ADBCF

ADPT

AGDXF

AGIO

AHKSY

AKBA

AKCA

ALDR

ALFVF

ALFVY

ALNA

ALTM

ALXEF

AMGDF

AMRX

ANAB

ANDE

APAFF

APEN

APNHF

APNHY

AQST

ARCH

AREVF

ARGGY

ASGLY

ASMB

ASNA

ASRT

ATRA

AVGR

AVLIF

AWRE

AXAS

BACHF

BACHY

BAFYY

BASFY

BBBY

BBVA

BBVXF

BCDA

BCEL

BEDU

BELFA

BFIN

BICEY

BIDU

BJCHF

BLCM

BLMN

BNFT

BNKHF

BORR

BOXS

BRKMY

BRVRF

BSET

BrightSphere Investment Group plc Ordinary Shares

BSIG

BVTEF

BXEFF

BZLFY

CADE

CALX

CAMP

CANL

New 52-Week Lows For Monday Morning

ALTIPLANO METALS INC ORD by Altiplano Metals Inc.

Altiplano Metals Inc

Multiple bets tied to the ongoing fire disaster in Los Angeles have surfaced on cryptocurrency-based prediction platform Polymarket, raising ethical concerns about such money-making opportunities.
What Happened: More than 30,000 people had to evacuate the Pacific Palisades neighborhood of Los Angeles as a catastrophic wildfire raged, endangering life and property.
In response, as many as 8 separate betting contracts came up on Polymarket, a Polygon (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">POL</a>)-based forecasting market that allows users to use cryptocurrencies to predict the outcome of events and make money.
One notable betting <a href="https://polymarket.com/event/will-the-palisades-fire-be-contained-by-friday">question</a> on the platform was, &#8220;Will&nbsp;the Palisades fire be contained&nbsp;by Friday?&#8221; on which about $87,000 has already been wagered. Bettors saw just a 2% possibility of this happening.
Another <a href="https://polymarket.com/event/will-palisades-fire-spread-to-santa-monica-by-sunday?tid=1736406268506">bet </a>was titled, &#8220;Will Palisades wildfire spread to Santa Monica by Sunday?&#8221; About 66% odds were in favor as of this writing.
These gambles sparked strong reactions from the public. Jacob R. Adkins, an X user, asked, &#8220;It says a lot about a society when we've resorted to entertaining ourselves by betting on how much worse a natural disaster could get.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">It says a lot about a society when we've resorted to entertaining ourselves by betting on how much worse a natural disaster could get.
&mdash; Jacob R. Adkins (@JacobRAdkins3) <a href="https://twitter.com/JacobRAdkins3/status/1877056992998555711?ref_src=twsrc%5Etfw">January 8, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Another user, going by the pseudonym corp_liberation, called the betting &#8220;immoral.&#8221;
&#8220;Why do you even have such a line?? These are people&#8217;s homes and lives. This is NOT a game!&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Betting on the spread of a fire is immoral. Why do you even have such a line?? These are people&#39;s homes and lives. This is NOT a game!
&mdash; corp_liberation (@corp_liberation) <a href="https://twitter.com/corp_liberation/status/1877135639860121700?ref_src=twsrc%5Etfw">January 8, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also:<a href="https://www.benzinga.com/24/12/42735744/pharma-bro-martin-shkreli-predicts-doom-for-michael-saylors-microstrategy-as-stock-dips-below-300-in-after-hours-trading"> </a><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42890745/us-government-granted-permission-to-liquidate-65-billion-in-bitcoin-seized-from-silk-road-case-report">US Government Silk Road Bitcoin Holdings Drop To 0 Amid Report DOJ Approved To Sell $6.5 Billion Worth Of Crypto</a>
Polymarket has attached a disclaimer for all its wildfire-related bets, stating that the idea was to provide factual, real-time news to those impacted by the calamity.
Note that Polymarket is not available to<a href="https://www.benzinga.com/24/11/41838037/will-polymarket-return-to-the-us-after-getting-trump-victory-right-ceo-says-its-part-of-the-plan" target="_blank" rel="noreferrer noopener"> U.S. residents </a>due to regulatory hurdles. The federally regulated prediction platform Kalshi didn&#8217;t have any such <a href="https://kalshi.com/markets/kxfema/states-that-declare-natural-disasters">bets </a>as yet.
Bettors <a href="https://polymarket.com/event/when-will-the-palisades-fire-be-fully-contained?tid=1736409008879" target="_blank" rel="noreferrer noopener">saw </a>a 65% possibility of the calamity getting fully contained by Jan. 31, according to the odds for the contract titled, "When will the Palisades wildfire be fully contained?""
Why It Matters: This isn&#8217;t the first time Polymarket has been in the spotlight for its betting markets on sensitive issues. 
Last year, the platform faced criticism for facilitating bets on the Israel-Hezbollah conflict. 
Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)&nbsp;co-founder Vitalik Buterin defended Polymarket, highlighting its role in <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41110897/ethereum-creator-vitalik-buterin-bats-for-polymarkets-model-amid-concerns-over-betting-on-">providing accurate information and preventing misinformation</a>. 
It&#8217;s worth noting that Buterin has skin in the game, having participated in Polymarket&#8217;s $70 million funding round in May of last year.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/25/01/42890191/trump-themed-nfts-launch-on-bitcoin-network-for-first-timeheres-what-you-should-know">Trump-Themed NFTs Debut On Bitcoin Network — One Card Gets Listed At $1.9 Million</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Representative Image. Photo Courtesy: Wikimedia

$ETH

$POL

Los Angeles Wildfires Will Be Tamed By This Day, Predict Polymarket Users — Observers Raise Ethical Question

The Tender Offer is for the outstanding notes listed in the table below (collectively, the "Notes" and each a "Series" of Notes), in the order of priority shown in the table below, and subject to the 2027 Notes Tender Cap set forth in the table below.
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">Title of Security</td>
<td colspan="1" rowspan="1">CUSIP(1)</td>
<td colspan="1" rowspan="1">Issuer</td>
<td colspan="1" rowspan="1">Aggregate Principal Amount Outstanding</td>
<td colspan="1" rowspan="1">2027 Notes Tender Cap(2) (in millions)</td>
<td colspan="1" rowspan="1">Acceptance Priority Level(3)</td>
<td colspan="1" rowspan="1">Reference U.S. Treasury Security</td>
<td colspan="1" rowspan="1">Early Tender Premium(4)</td>
<td colspan="1" rowspan="1">Fixed spread (basis points)</td>
<td colspan="1" rowspan="1">Bloomberg Reference Page(5)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
6.375% Senior Notes due 2027
(the "2027 Notes")&#x2A;
</td>
<td colspan="1" rowspan="1">
403949 AK6
U4322C AD5
403949 AP5
</td>
<td colspan="1" rowspan="1">HF Sinclair</td>
<td colspan="1" rowspan="1">$399,875,000</td>
<td colspan="1" rowspan="1">$150,000,000</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">2.625% U.S.T. due 4/15/25</td>
<td colspan="1" rowspan="1">$30.00</td>
<td colspan="1" rowspan="1">50 bps</td>
<td colspan="1" rowspan="1">FIT3</td>
</tr>
<tr>
<td colspan="1" rowspan="1">5.875% Senior Notes due 2026&#x2A;</td>
<td colspan="1" rowspan="1">
403949 AF7
U4322C AB9
403949 AB6
</td>
<td colspan="1" rowspan="1">HF Sinclair</td>
<td colspan="1" rowspan="1">$797,100,000</td>
<td colspan="1" rowspan="1">N/A.</td>
<td colspan="1" rowspan="1">2</td>
<td colspan="1" rowspan="1">4.250% U.S.T. due 12/31/25</td>
<td colspan="1" rowspan="1">$30.00</td>
<td colspan="1" rowspan="1">50 bps</td>
<td colspan="1" rowspan="1">FIT4</td>
</tr>
<tr>
<td colspan="1" rowspan="1">5.875% Senior Notes due 2026&#x2A;</td>
<td colspan="1" rowspan="1">436106AA6</td>
<td colspan="1" rowspan="1">HollyFrontier</td>
<td colspan="1" rowspan="1">$202,900,000</td>
<td colspan="1" rowspan="1">N/A.</td>
<td colspan="1" rowspan="1">3</td>
<td colspan="1" rowspan="1">4.250% U.S.T. due 12/31/25</td>
<td colspan="1" rowspan="1">$30.00</td>
<td colspan="1" rowspan="1">50 bps</td>
<td colspan="1" rowspan="1">FIT4</td>
</tr>
</tbody>
</table>
</figure>

DINO

Reported Earlier, HF Sinclair Upsizes Cash Tender Offer To $1.05B For Outstanding Debt Securities

NYMT

Reported Earlier, New York Mortgage Trust Prices $75M 9.125% Senior Notes Due 2030 With Nasdaq Listing Planned

Recent Highlights &amp; Accomplishments
<ul>
<li>Generated preliminary unaudited fourth quarter revenue of approximately&nbsp;$8.3 million, and preliminary unaudited full year 2024 total revenue of approximately&nbsp;$22.5 million</li>
<li>Received FDA approval for Eversense&#xAE; 365 Continuous Glucose Monitoring system and launched Eversense 365 with commercial partner, Ascensia.</li>
<li>Patient base increased 56% in 2024 over 2023 to approximately 6,000 global patients</li>
<li>Reached a milestone of over a 1,000 annual U.S. Eversense prescribers during 2024</li>
<li>Continued strong interest in Eversense 365, as evidenced by the following early U.S. launch performance indicators:
<ul>
<li>Direct to Consumer (DTC) leads have doubled in Q4 compared to the pre-launch third quarter</li>
<li>New patient shipments of approximately 600 in December were the highest monthly total in the Company's history</li>
<li>The number of patients switching to Eversense from competitive CGM's has increased 49% since Eversense 365 launch</li>
<li>118% increase in patient referrals from physicians since launch</li>
</ul>
</li>
<li>Following recent appreciation in Company's share price, determined not to proceed with previously announced Special Meeting of stockholders to consider reverse stock split.</li>
</ul>
 &nbsp;

SENS

Reported Earlier, Senseonics Reports $22.5M Preliminary 2024 Revenue With $8.4M In Q4, 56% YoY Patient Growth, And Milestone Eversense 365 Launch Success

Palantir Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) Chief Technology Officer Shyam Sankar highlighted the limitations of automation in enterprise artificial intelligence, as the data analytics firm faces renewed scrutiny over its soaring valuation and recent institutional selling.
What Happened: &#8220;If all of the value is in automation, what have we been doing for the last 20 years with self-driving cars? We&#8217;ve been handling edge cases,&#8221; Sankar stated, emphasizing that automation&#8217;s effectiveness is constrained by exceptional scenarios that require human oversight.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">"[With LLMs], the value is in automation, and in enterprise autonomy. Maybe you can be 50% more productive with a copilot, but [unlocking] all of the economic value requires thinking about AI as a type of labor." Watch Palantir CTO <a href="https://twitter.com/ssankar?ref_src=twsrc%5Etfw">@ssankar</a> explain why the most powerful… <a href="https://t.co/57bShrdI6v">pic.twitter.com/57bShrdI6v</a>
&mdash; Palantir (@PalantirTech) <a href="https://twitter.com/PalantirTech/status/1876991053842055327?ref_src=twsrc%5Etfw">January 8, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The comments come as Cathie Wood&#8216;s ARK Invest sold 196,728 PLTR <a href="https://www.benzinga.com/trading-ideas/technicals/25/01/42843542/palantir-stock-the-ark-is-rocking-as-palantirs-rally-hits-resistance">shares worth approximately</a> $15 million across its flagship funds, including ARK Innovation ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#NYSE">ARKK</a>) and ARK Next Generation Internet ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKW#NYSE">ARKW</a>). 
The sale follows Morgan Stanley&#8216;s recent &#8220;underweight&#8221; rating and $60 price target, despite the stock&#8217;s remarkable 355% surge over the past year.
See Also: <a href="https://www.benzinga.com/markets/equities/25/01/42890496/cybertruck-was-my-hero-today-says-ross-gerber-after-teslas-truck-allowed-him-to-navigate-california-wildfires-in-safety">&#8216;Cybertruck Was My Hero Today,&#8217; Says Ross Gerber After Tesla&#8217;s Truck Allowed Him To Navigate California Wildfires In Safety</a>
Why It Matters: The institutional selling presents a stark contrast to CNBC host Jim Cramer&#8216;s bullish stance, who recently indicated interest in adding <a href="https://www.benzinga.com/markets/equities/25/01/42806417/jim-cramer-works-sunday-brainstorm-on-buying-palantir-and-tesla-stock-calls-them-protective-intellectual-blankets">PLTR to his portfolio</a>. The stock has attracted increased <a href="https://www.benzinga.com/news/global/24/12/42331892/trump-eyes-shyam-sankar-for-pentagon-role-while-palantir-gains-from-border-crisis-contracts-analyst-says-this-is-a-win-for-the-stock">attention amid reports</a> that Sankar is being considered for a top Pentagon research position.
Wedbush Securities Managing Director Dan Ives identifies Palantir as a leader in <a href="https://www.benzinga.com/news/global/24/12/42331892/trump-eyes-shyam-sankar-for-pentagon-role-while-palantir-gains-from-border-crisis-contracts-analyst-says-this-is-a-win-for-the-stock">enterprise AI transformation</a>, though government revenue growth slowed to 10% in 2023 from over 20% in 2022.
Trading at a reported 80% premium compared to <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/01/42811388/palantir-trades-in-the-red-during-monday-premarket-as-morgan-stanley-assigns-underw">high-growth software peers</a>, PLTR closed at $68.23 on Wednesday, with <a href="https://www.benzinga.com/quote/PLTR/analyst-ratings">analyst price targets</a> ranging widely from UBS&#8217;s $80 to Wolfe Research&#8217;s $7.50, reflecting the market&#8217;s divided outlook on the company&#8217;s valuation.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/01/42890464/softbank-owned-arm-eyes-acquisition-of-oracle-backed-chip-designer-ampere-computing-amid-nvidias-dominance-report">SoftBank-Owned Arm Eyes Acquisition Of Oracle-Backed Chip Designer Ampere Computing Amid Nvidia&#8217;s Dominance: Report</a></li>
</ul>
Image Via Shutterstock 
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

ARKK

ARKW

PLTR

Palantir CTO Shyam Sankar Challenges Automation's Potential As Selling Pressure Mounts: 'What Have We Been Doing For 20 Years?'

Avadel Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVDL#NASDAQ">AVDL</a>) slipped by 25.63% in after-hours on Wednesday after it missed the fourth quarter sales estimate by 5.12%. Still, the sales of its narcolepsy drug, LUMRYZ rose by 150% on an annual basis.
What Happened: The preliminary earnings results for the fourth quarter pegged a 150% increase in net product revenue to $50 million, as compared to $19.5 million in the fourth quarter of 2023. This missed the consensus analyst estimate by 5.12%, which was <a href="https://www.benzinga.com/quote/AVDL/earnings">expected </a>to be $52.7 million, according to <a href="https://www.benzinga.com/quote/AVDL/earnings">Benzinga</a>.
The biopharmaceutical company is focused on treating cataplexy, excessive daytime sleepiness, and other sleep disorders in adults and children above seven.
The company reported a full-year net product revenue of approximately $169 million compared to $28 million in 2023. Its cash flow from operations stood at approximately $73 million for the quarter ended Dec. 31, 2024.
Greg Divis, CEO of Avadel Pharmaceuticals, highlighted 2024 as a pivotal year, emphasizing the consistent patient adoption of LUMRYZ and the overwhelmingly positive feedback from both patients and providers regarding the life-changing benefits of its once-nightly dosing regimen.
See Also: <a href="https://www.benzinga.com/general/market-summary/25/01/42871340/regional-banks-can-thrive-despite-big-bank-dominance-truist-securities-highlights-three-key-paths-for-thriving-regional-banks">Regional Banks Can Thrive Despite Big Bank Dominance: Truist Securities Highlights Three Key Paths For Thriving Regional Banks</a>
Why It Matters: There was a 275% increase from 900 patients on LUMRYZ in 2023 to 2,500 in 2024. According to its press release, demand continued across all three patient segments in the fourth quarter, with 34% of patients being new to oxybates and 38% switching from first-generation oxybates.
The company expects the net product revenue for 2025 in the range of $240 million to $260 million, representing a 50% increase at the midpoint of guidance from 2024 and a positive cash flow of $20 million – $40 million.
Divis added that moving into 2025, the company is refining its strategy to increase LUMRYZ&#8217;s demand and aiming to drive uptake across all narcolepsy patient segments. &#8220;We&#8217;re well-positioned to lead in the sleep space and transform care for patients with sleep disorders.&#8221; he said.
Price Action: Avadel shares have fallen by 32.72% over the last six months, underperforming the Nasdaq Biotechnology Index, which fell by 5.07% in the same period. Furthermore, the exchange-traded fund tracking the index, iShares Biotechnology ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBB#NASDAQ">IBB</a>) fell 2.9% over the last six months.
According to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data, AVDL has a consensus price target of $20.9 per share, with a &#8216;buy&#8217; rating based on the ratings of 10 <a href="https://www.benzinga.com/quote/SERV/analyst-ratings">analysts</a>. The highest price target out of all the analysts tracked by Benzinga is $30 issued by Oppenheimer as of Oct. 31, 2024. The lowest target price is $11 per share issued by Jefferies on Nov. 30, 2024.
The average price target between HC Wainwright &amp; Co., Needham, and Needham implies an 189.31% upside for AVDL.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/quote/SERV/analyst-ratings"><img loading="lazy" decoding="async" width="946" height="355" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/09010640/AVDL-ANR.png" alt="" class="wp-image-725276" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/09010640/AVDL-ANR.png 946w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/09010640/AVDL-ANR-300x113.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/09010640/AVDL-ANR-768x288.png 768w" sizes="(max-width: 946px) 100vw, 946px" /></a></figure>
Photo Courtesy: Pixabay.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/market-summary/25/01/42867184/yield-curve-normalization-cheap-valuation-eps-growth-to-boost-banks-in-2025-truist-initiates-coverage-on-these-14-regional-names">Yield Curve Normalization, Cheap Valuation, EPS Growth To Boost Banks In 2025: Truist Initiates Coverage On These 14 Regional Names</a></li>
</ul>

Earnings

Earnings Misses

Broad U.S. Equity ETFs

Analyst Ratings

ETFs

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

AVDL

Avadel Pharmaceuticals Misses Earnings Estimates But Posts 150% Sales Increase From  Narcolepsy Drug LUMRYZ

Burak brings over 27 years of extensive international experience within the finance sector. Burak started his career with Xerox where he held a number of key financial positions in the USA and the UK in addition to serving as the General Manager of Xerox Turkey. More recently Burak has held the position of Chief Financial Officer within the global Digital Transformation, IT Solutions &amp; Cybersecurity space

VEON

VEON Appoints Burak Ozer As CFO, Effective January 9, 2025

Macro Economic Events

Econ #s

Economics

Germany Trade Balance For November 19.7B Vs. 14.7B	Est.; 13.4B Prior

Germany Industrial Production (MoM) For November 1.5% Vs. 0.5% Est.; -0.4% (Revised) Prior

Company Strengthens Long-term Strategy With Agile Adaptability in Rapidly Changing Business Environments

Reported Earlier, LG Electronics CEO William Cho Reveals 2025 Strategy To Build Structural Competitiveness And Drive Qualitative Growth

Comments

Altiplano Metals

News

Latest news for Altiplano Metals (OTC:ALTPF) Stock

Wednesday, August 21, 2019

Monday, August 05, 2019

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga